Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine in Late-life Depression
NCT06591091Phase 2Recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in major depressive disorder (MDD), sponsored by University of Illinois Chicago. Started Dec 2025; status: recruiting.
02
Drugs
clemastine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06591091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06591091.